ATyr Pharma (LIFE) Competitor Comparison
We are evaluating the key criteria listed to compare ATyr Pharma (LIFE) against its competitors in the Biotechnology industry.
Market Capitalization
254 / 368Gross Profits
182 / 278Total Revenue
182 / 300EBITDA
134 / 337Free Cashflow
154 / 352Quick Ratio
112 / 357Earnings per Share
118 / 359Dividend yield
0 / 6Total Cash
214 / 358Performance 3 years
184 / 368Performance 5 years
159 / 368Performance 10 years
327 / 368Linearity 3 years
116 / 368Linearity 5 years
62 / 368Linearity 10 years
317 / 367Total Rank
194 / 368Dividend Rank
368 / 368Valuation Rank
87 / 368Piotroski Rank
211 / 368Muliplier Rank
28 / 368Market Capitalization - LIFE ranking 254 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.